Private equity acquisition of gastroenterology practices led to higher prices and spending but had no discernible effect on quality, according to a new analysis of data on more than 1.1 million patients across thousands of practice sites between 2012 and 2021. James Leavitt, MD, an immediate past president and the chief clinical officer for Miami-based Gastro Health, one of the largest and most active PE-backed consolidators in the GI space, questioned the study’s conclusions.
Read the full article: Higher Costs, Unchanged Quality Seen in Study on PE-Backed GI //
Source: https://www.gastroendonews.com/PRN/Article/09-25/Private-Equity-Gastroenterology-Acquisition-Effects/78105